Company Number: 14525000

Analysis Date: 2025-07-20 14:18 UTC

Financial Health Assessment: ALAV & CO LIMITED (As of 31 December 2023)

---

1. Financial Health Score: Grade D

Explanation:
The company is currently experiencing financial distress, reflected in negative net assets and net current assets (working capital deficit). The liabilities exceed current assets, indicating liquidity issues and an inability to cover short-term obligations comfortably. This score signals warning signs that need urgent attention but does not yet indicate insolvency.

---

2. Key Vital Signs:

Metric	Value (£)	Interpretation
Current Assets	2,166,090	Reasonably strong asset base, mainly stock
Cash	69,343	Low cash reserves; limited immediate liquidity
Debtors	56,448	Modest receivables; some cash expected soon
Current Liabilities	2,399,672	High short-term obligations; potential pressure
Net Current Assets	-233,582	Negative working capital ("symptom of distress")
Net Assets (Shareholders' Funds)	-233,582	Negative equity, indicating accumulated losses
Share Capital	1	Minimal capital base; essentially a shell equity

Interpretation of Vital Signs:

• Negative Net Current Assets: The company’s short-term debts surpass its short-term assets by £233,582, which is a worrying sign of liquidity strain. This means it may struggle to meet obligations as they fall due without converting stock or obtaining additional financing.
• Stock Dominance: The bulk of current assets (£2,040,299) is in stock, which can be less liquid than cash or receivables. If this stock is slow-moving or obsolete, it could exacerbate liquidity problems.
• Low Cash on Hand: Only £69,343 in cash limits the company's ability to handle immediate expenses or emergencies.
• Negative Equity: Net liabilities indicate accumulated losses since incorporation, undermining financial stability and potentially limiting borrowing capacity.

---

3. Diagnosis:

The company shows clear symptoms of financial distress, primarily due to its inability to cover short-term liabilities with liquid assets. The heavy reliance on stock as an asset raises concerns about asset liquidity and inventory management. Negative shareholders' funds suggest that the business has been running at a loss or has significant unpaid liabilities since its inception in December 2022.

This financial picture is common in early-stage companies that have invested heavily in stock or fixed assets but have yet to generate sufficient revenue or convert stock into cash. However, the negative working capital and equity position indicate a fragile financial health status, with risk of cash flow problems if sales do not improve or if creditors demand payment.

---

4. Recommendations:

Immediate Actions:

• Improve Cash Flow: Prioritize converting stock into sales or liquid assets to increase cash on hand. Consider sales promotions or discounts if stock turnover is slow.
• Negotiate with Creditors: Engage suppliers and creditors to extend payment terms, easing immediate cash pressure.
• Review Inventory Management: Conduct a thorough review of stock to identify obsolete or slow-moving items and write-down if necessary to reflect realistic realizable value.
• Seek Additional Funding: Explore options for equity injection or short-term borrowing to bolster working capital and stabilize liquidity.
• Monitor Debtor Collections: Accelerate collection of outstanding debts to improve cash inflows.

Medium-Term Focus:

• Profitability Measures: Review pricing, cost control, and operational efficiencies to move toward profitability and rebuild equity.
• Financial Planning: Implement robust budgeting and cash flow forecasting to anticipate liquidity needs and avoid distress symptoms.
• Governance and Reporting: Ensure timely and accurate financial reporting to maintain transparency with stakeholders, including the sole shareholder and any lenders.

---

Medical Analogy Summary:

ALAV & CO LIMITED is currently showing "symptoms of financial distress" similar to a patient with low blood pressure and dehydration—its liquidity is weak with insufficient "fluid" (cash) circulating to meet immediate needs. The company’s "immune system" (equity base) is compromised, making it vulnerable to shocks. Without intervention to improve "circulation" (cash flow) and "nutrient intake" (sales/profits), the company risks further deterioration.

---